Skip Header

 
Contribute Send feedback
Read comments (1) or add your own

Reviewed, UniProtKB/Swiss-Prot Q9NZ20 (PA2G3_HUMAN)

Last modified June 16, 2009. Version 76. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (5) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Group 3 secretory phospholipase A2
    EC=3.1.1.4
Alternative name(s):
    Group III secretory phospholipase A2
      Short name=GIII sPLA2
    Phosphatidylcholine 2-acylhydrolase GIII
    sPLA2-III
Gene names
Name: PLA2G3
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length509 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is further processed into a mature form.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. Shows an 11-fold preference for phosphatidylglycerol over phosphatidylcholine (PC). Preferential cleavage: 1-palmitoyl-2-linoleoyl-phosphatidylethanolamine (PE) > 1-palmitoyl-2-linoleoyl-PC > 1-palmitoyl-2-arachidonoyl-PC > 1-palmitoyl-2-arachidonoyl-PE. Ref.4

Catalytic activity

Phosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate.

Cofactor

Binds 1 calcium ion per subunit.

Enzyme regulation

Arachidonic acid release is markedly increased by glypican, a glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan.

Subcellular location

Secreted. Cell membrane. Ref.4

Tissue specificity

Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). Ref.5

Induction

By IL1B and TNF in microvascular endothelial cells (at protein level). Ref.5

Post-translational modification

N-glycosylation does not affect the catalytical activity, but is required for proper secretion. A nonglycosylated form was observed in several cell types. Ref.5

In several cell types, the N- and C-termini are cleaved off.

Sequence similarities

Belongs to the phospholipase A2 family.

Ontologies

Keywords
   Biological processLipid degradation
   Cellular componentCell membrane
Membrane
Secreted
   Coding sequence diversityPolymorphism
   DomainSignal
   LigandCalcium
Metal-binding
   Molecular functionHydrolase
   PTMDisulfide bond
Glycoprotein
Phosphoprotein
Gene Ontology (GO)
   Biological processlipid catabolic process

Inferred from electronic annotation. Source: UniProtKB-KW

phospholipid metabolic process Ref.1

Traceable author statement. Source: ProtInc

   Cellular componentextracellular space Ref.1

Traceable author statement. Source: ProtInc

plasma membrane

Inferred from electronic annotation. Source: UniProtKB-SubCell

   Molecular functioncalcium ion binding

Inferred from electronic annotation. Source: UniProtKB-KW

calcium-dependent phospholipase A2 activity Ref.1

Traceable author statement. Source: ProtInc

Complete GO annotation...

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Signal peptide1 – 1919 Potential
Chain20 – 509490Group 3 secretory phospholipase A2
PRO_0000022992

Regions

Region150 – 291142Phospholipase A2-like

Sites

Active site1841
Active site2141 By similarity
Metal binding1581Calcium; via carbonyl oxygen By similarity
Metal binding1601Calcium; via carbonyl oxygen By similarity
Metal binding1621Calcium; via carbonyl oxygen By similarity
Metal binding1851Calcium By similarity

Amino acid modifications

Modified residue3261Phosphothreonine Ref.6
Modified residue3271Phosphothreonine Ref.6
Modified residue3351Phosphoserine Ref.6
Glycosylation1671N-linked (GlcNAc...) Ref.5
Glycosylation2801N-linked (GlcNAc...) Ref.5
Glycosylation3251N-linked (GlcNAc...) Potential
Glycosylation3961N-linked (GlcNAc...) Potential
Glycosylation4391N-linked (GlcNAc...) Potential
Disulfide bond159 ↔ 181 By similarity
Disulfide bond180 ↔ 220 By similarity
Disulfide bond187 ↔ 213 By similarity
Disulfide bond211 ↔ 244 By similarity

Natural variations

Natural variant701A → S: dbSNP rs2232176.
VAR_024555
Natural variant1161E → Q: dbSNP rs2074734.
VAR_024556
Natural variant1571L → V: dbSNP rs2074735.
VAR_020288
Natural variant3071H → Y: dbSNP rs2232180.
VAR_056581
Natural variant3221S → R: dbSNP rs2072193.
VAR_024557
Natural variant3781R → Q: dbSNP rs2232183.
VAR_034366

Experimental info

Mutagenesis1671N → S: Loss of glycosylation. Ref.5
Mutagenesis1841H → Q: Loss of PGE2 synthesis. Ref.4 Ref.5
Mutagenesis2801N → S: Loss of glycosylation. Ref.5

Sequences

Sequence LengthMass (Da)Tools
Q9NZ20-1 [UniParc].

Last modified October 1, 2000. Version 1.
Checksum: 2D610DECA6EE6CF8

FASTA50957,151
        10         20         30         40         50         60 
MGVQAGLFGM LGFLGVALGG SPALRWYRTS CHLTKAVPGN PLGYLSFLAK DAQGLALIHA 

        70         80         90        100        110        120 
RWDAHRRLQA CSWEDEPELT AAYGALCAHE TAWGSFIHTP GPELQRALAT LQSQWEACRA 

       130        140        150        160        170        180 
LEESPAGARK KRAAGQSGVP GGGHQREKRG WTMPGTLWCG VGDSAGNSSE LGVFQGPDLC 

       190        200        210        220        230        240 
CREHDRCPQN ISPLQYNYGI RNYRFHTISH CDCDTRFQQC LQNQHDSISD IVGVAFFNVL 

       250        260        270        280        290        300 
EIPCFVLEEQ EACVAWYWWG GCRMYGTVPL ARLQPRTFYN ASWSSRATSP TPSSRSPAPP 

       310        320        330        340        350        360 
KPRQKQHLRK GPPHQKGSKR PSKANTTALQ DPMVSPRLDV APTGLQGPQG GLKPQGARWV 

       370        380        390        400        410        420 
CRSFRRHLDQ CEHQIGPREI EFQLLNSAQE PLFHCNCTRR LARFLRLHSP PEVTNMLWEL 

       430        440        450        460        470        480 
LGTTCFKLAP PLDCVEGKNC SRDPRAIRVS ARHLRRLQQR RHQLQDKGTD ERQPWPSEPL 

       490        500 
RGPMSFYNQC LQLTQAARRP DRQQKSWSQ 

« Hide

References

« Hide 'large scale' references
[1]"Novel human secreted phospholipase A2 with homology to the group III bee venom enzyme."
Valentin E., Ghomashchi F., Gelb M.H., Lazdunski M., Lambeau G.
J. Biol. Chem. 275:7492-7496(2000) [PubMed: 10713052] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION.
[2]"The DNA sequence of human chromosome 22."
Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M. expand/collapse author list , Buck D., Burgess J., Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A., Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C., Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L., Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L., Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N., Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R., Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y., Wright H.
Nature 402:489-495(1999) [PubMed: 10591208] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[3]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Tissue: Brain.
[4]"Cellular arachidonate-releasing function of novel classes of secretory phospholipase A2s (groups III and XII)."
Murakami M., Masuda S., Shimbara S., Bezzine S., Lazdunski M., Lambeau G., Gelb M.H., Matsukura S., Kokubu F., Adachi M., Kudo I.
J. Biol. Chem. 278:10657-10667(2003) [PubMed: 12522102] [Abstract]
Cited for: FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF HIS-184.
[5]"Cellular distribution, post-translational modification, and tumorigenic potential of human group III secreted phospholipase A(2)."
Murakami M., Masuda S., Shimbara S., Ishikawa Y., Ishii T., Kudo I.
J. Biol. Chem. 280:24987-24998(2005) [PubMed: 15863501] [Abstract]
Cited for: TISSUE SPECIFICITY, INDUCTION, GLYCOSYLATION AT ASN-167 AND ASN-280, MUTAGENESIS OF ASN-167; HIS-184 AND ASN-280.
[6]"A quantitative atlas of mitotic phosphorylation."
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-326; THR-327 AND SER-335, MASS SPECTROMETRY.
+Additional computationally mapped references.

Cross-references

Sequence databases

AF220490 mRNA. Translation: AAF44746.1.
AC005005 Genomic DNA. Translation: AAD15617.1.
BC025316 mRNA. Translation: AAH25316.1.
IPIIPI00024578.
RefSeqNP_056530.2.
UniGeneHs.149623

3D structure databases

HSSPHSSP built from PDB template 1POC based on UniProtKB P00630.
ModBaseSearch...

PTM databases

PhosphoSiteQ9NZ20.

Proteomic databases

PRIDEQ9NZ20.

Genome annotation databases

EnsemblENSG00000100078. Homo sapiens. [Contig view]
GeneID50487.
KEGGhsa:50487.

Organism-specific databases

GeneCardsGC22M029855.
H-InvDBHIX0016386.
HGNCHGNC:17934. PLA2G3.
HPAHPA018314.
MIM611651. gene.
PharmGKBPA38267.
GenAtlasSearch...

Phylogenomic databases

HOGENOMQ9NZ20.
HOVERGENQ9NZ20.

Enzyme and pathway databases

BRENDA3.1.1.4. 247.

Gene expression databases

BgeeQ9NZ20.
CleanExHS_PLA2G3.
GermOnlineENSG00000100078. Homo sapiens.

Family and domain databases

InterProIPR016090. Phospholipase_A2.
IPR013090. Phospholipase_A2_AS.
IPR001211. Phospholipase_A2_euk.
IPR008774. Phospholipase_A2_met.
[Graphical view]
Gene3DG3DSA:1.20.90.10. Phospholipase_A2. 1 hit.
PANTHERPTHR12253. Phospholipase_A2_met. 1 hit.
PfamPF05826. Phospholip_A2_2. 1 hit.
[Graphical view]
SMARTSM00085. PA2c. 1 hit.
[Graphical view]
PROSITEPS00119. PA2_ASP. False negative.
PS00118. PA2_HIS. 1 hit.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio53048.
SOURCESearch...

Entry information

Entry namePA2G3_HUMAN
AccessionPrimary (citable) accession number: Q9NZ20
Secondary accession number(s): O95768
Entry history
Integrated into UniProtKB/Swiss-Prot: February 11, 2002
Last sequence update: October 1, 2000
Last modified: June 16, 2009
This is version 76 of the entry and version 1 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)

Relevant documents

Human chromosome 22

Human chromosome 22: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents